• en
  • it
  • de
  • Farmabios Breaks Ground to Expand its Manufacturing Footprint in Gropello Cairoli (Italy)

    As part of an ongoing investment program to enhance PharmaZell Group’s production output, we have initiated the construction of a brand new large steroid building and a new warehouse on the Farmabios premises in Gropello Cairoli (Italy). Construction work began in Dec 2019, a symbolic ground breaking ceremony is planned for Mar 2020.

    The investment plan comprises a staged introduction of new state of the art steroid production lines, the first to be operational in the 2nd half of 2021. This investment plan underlines our commitment to this strategic portfolio and will allow us to increase our leadership in steroids in the years to come. We will keep you up-dated on the progress regularly. !

    More News and Fairs

    Private Equity owner Bridgepoint visits PharmaZell Group’s company Farmabios

    In October 2020 our new investor Bridgepoint visited the Farmabios site in Gropello-Cairolli (Italy). Besides holding its regular board meeting, the attendees went on an extensive plant tour. They were

    FarmaBios – Update on construction of new steroid building in Gropello Cairoli (Italy)

    The construction of the new steroid building is even in Covid-19 times running smoothly and almost on schedule. The department would have three layers for 980 m3 total with a

    New ISO Certificates for FarmaBios (Gropello Cairoli, Italy)

    FarmaBios successfully completed the certification process in accordance with the ISO 45001:2018 standards. The new certificate is the last achievement of the list together with ISO 9001:2015 and ISO 14001:2015.

    FarmaBios – Update on new warehouse in Gropello Cairoli (Italy)

    We are pleased to share the last updates on new warehouse building, indeed the works are on schedule: the first storage racks have been already installed. The warehouse would have

    PharmaZell (India) Private Limited. – Vizag

    Vizag Unit has got approval from Board to expand 5ASA for one more separate 180 TPA manufacturing facility. Site clearance is given and the Civil work inaugural was organised on

    Farmabios expands its Manufacturing Footprint in Gropello Cairoli (Italy)

    The construction of a brand new large steroid building and a new warehouse on the Farmabios premises in Gropello Cairoli (Italy) is moving forward nearly in plan. After construction work

    Acquisition of PharmaZell Group by Bridgepoint completed. PharmaChol fully owned by the PharmaZell Group.

    Bridgepoint, an international asset management firm with over €20 billion of assets, announced the acquisition of the PharmaZell Group in February 2020. After obtaining all necessary authorizations, we are very

    CURRENT COVID-19 OUTBREAK: SUPPORTIVE HELP

    Farmabios is pleased to announce that it has just finalized the production and distribution of sanitizing gels to Covid-19 task forces and structures which are serving the neighboring area, as

    UPDATE 4: IMPACT OF THE CURRENT COVID-19 OUTBREAK ON INDIAN PRODUCTION SITES

    PharmaZell Group is very conscious of our important role and duty in delivering APIs to our customers and being an active part in maintaining the health system running. Up to

    FarmaBios activities are regularly proceeding…

    During this critical and challenging period, Farmabios SpA states that our activities are regularly proceeding. We are conscious of the role and duty in delivering APIs, and our active part

    Breaking News: PharmaZell Group acquired by Bridgepoint

    The PharmaZell Group management is very pleased to inform that the Group was acquired by Bridgepoint from DPE Deutsche Private Equity and Maxburg Capital Partners for an undisclosed sum. Bridgepoint

    Farmabios Breaks Ground to Expand its Manufacturing Footprint in Gropello Cairoli (Italy)

    As part of an ongoing investment program to enhance PharmaZell Group’s production output, we have initiated the construction of a brand new large steroid building and a new warehouse on

    Renewed GMP Certificate for our Manufacturing Facility Farmabios in Gropello Cairoli (Italy)

    We are very glad to announce that the competent Italian authority (AIFA) has issued a renewed GMP certificate for our Farmabios SpA production facility [http://eudragmdp.ema.europa.eu/inspections/gmpc/generateGMPCPDF.do].

    Farmabios expands its portfolio with Cannabidiol API

    Global API supplier Farmabios announced today the addition of an ultra-pure synthetic Cannabidiol (CBD) drug substance to its portfolio. With an EU Drug Master File and cGMP manufacturing capacities, Farmabios